Reviewed clinical summary · Source-linked · Educational use only

Intermittent Islamic Fasting Plus Lifestyle vs Lifestyle Alone in Metabolic Syndrome: A Small RCT

Hormone Insight visual abstract summarising intermittent Islamic fasting plus lifestyle in metabolic syndrome.

Clinical Bottom Line

A 54-patient randomized trial testing intermittent Islamic fasting added to lifestyle modification against lifestyle modification alone in adults with metabolic syndrome, with greater percent-change improvements in weight and metabolic markers in the fasting arm. PICO summary and expert commentary.

Summary: In 54 adults aged 30 to 45 with metabolic syndrome, adding intermittent Islamic fasting (two weekly sunnah fasts plus three mid-lunar-month days) to lifestyle modification was compared with lifestyle modification alone in a single-centre randomized controlled trial. Both arms improved after the intervention, and absolute endpoint parameters did not differ significantly between groups; however, the fasting arm showed significantly greater percent-change improvements in weight, waist circumference, blood pressure, fasting glucose, lipids and HDL (most p<0.001). Effect sizes and confidence intervals were not reported in the abstract.

PICO Summary

ElementDetail
Population54 adults aged 30 to 45 with metabolic syndrome; single-centre clinical nutrition outpatient clinic, Egypt; recruited August 2023 to February 2024.
InterventionIntermittent Islamic fasting plus lifestyle modification (n=27). Fasting comprised two days weekly (Monday and Thursday) plus the 13th, 14th and 15th of each lunar month, alongside diet and physical-activity advice.
ComparisonLifestyle modification alone (n=27), comprising the same diet and physical-activity recommendations without prescribed fasting.
OutcomeNo significant between-group difference was seen in absolute clinical or laboratory endpoints, and both arms improved. Between-group differences in percent change favoured the fasting arm for weight (p<0.001), waist circumference (p<0.001), systolic blood pressure (p=0.042), diastolic blood pressure (p<0.001), fasting blood glucose (p<0.001), triglycerides (p<0.001), HDL (p<0.001) and total cholesterol (p=0.023). Effect estimates, 95% CIs and ARR/NNT were not reported in the abstract.
RCT BMC Public Health · 2025

Islamic fasting in metabolic syndrome

RCT · metabolic syndrome · 6 months

Trial design
Adults 30-45, metabolic syndr. Enrolled & assessed RANDOMISED 1:1 Fasting + lifestyle Islamic fasting + diet n = 27 Lifestyle alone Diet + activity only n = 27 Percent change in weight and metabolic markers
Change from baseline — both arms
% of baseline weight Baseline 6 months -8.0% vs -2.9% (p<0.001) Fasting + lifestyle Lifestyle alone
Weight Δ
-8.0% vs -2.9%
p<0.001
Waist Δ
-8.2% vs -2.4%
p<0.001
Fasting glucose Δ
-9.8% vs -1.7%
p<0.001
Triglycerides Δ
-14% vs -6.1%
p<0.001
⬡ Bottom Line

Fasting added to lifestyle gave significantly larger percent-change improvements in weight and metabolic markers, but absolute endpoints did not differ between arms and the trial was small and open-label.

Expert Commentary

This single-centre randomized trial offers an early signal that structured intermittent Islamic fasting, layered onto standard lifestyle advice, may amplify metabolic improvement in adults with metabolic syndrome. The verdict, however, must stay cautious. The headline benefits are expressed as between-group differences in percent change, while absolute endpoint values did not differ significantly between arms and both groups improved, so much of the gain reflects shared lifestyle modification rather than fasting alone. The dominant limitation is statistical fragility: with only 27 patients per arm and no reported effect sizes, confidence intervals or adjustment for multiple comparisons, the cluster of very low p-values should be read as hypothesis-generating, not definitive. The open-label design, in which neither participants nor assessors could be blinded to a behavioural intervention, further inflates the risk of performance and reporting bias, and self-reported adherence to a faith-based fast is difficult to verify. Generalisability is narrow given the single Egyptian centre and the 30-to-45 age band. Can I use this with my patients? Not yet as a prescribed therapy, though it offers reassurance for a motivated Muslim patient already practising sunnah fasting who also commits to diet and activity changes. Larger, adequately powered, multi-centre trials reporting absolute effects and adherence data are needed before firmer recommendations can be made.

References

Nofal HA, Elmor AAR, AbdAllah AM, Zaitoun NA, Andargeery SY, Sharafeddin MA, et al. Effect of intermittent Islamic fasting in management of metabolic syndrome: a randomized control trial. BMC Public Health. 2025;25(1):2476. doi:10.1186/s12889-025-23493-7

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.